-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
-
First Congress of Interventional Pulmonology & EBUS and the XI South American Bronchology Congresses
Posted: February 2017 By Luis E. Raez, MD, FACP, FCCP The First Congress of Interventional Pulmonology & Endobronchial Ultrasound (EBUS) and the XI South American Bronchology Congresses were both a success. These events, sponsored by IASLC, occurred in Lima Peru on December 1–2, 2017, and were attended by 92 doctors from 27 Latin-American countries. IASLC…
-
Lung Cancer in Never-Smokers: An Epidemiologic Perspective
Posted: February 2017 By Chee-Keong Toh, MD, and Daniel SW Tan, MD The recent decade has seen much interest in lung cancer in never-smokers (LCNS), in most part attributed to the expanding number of therapeutically tractable alterations enriched within this clinical phenotype.1 However, equally relevant are studies directed at understanding the etiology of LCNS, for…
-
Sumitra Thongprasert, MD
Posted: February 2017 Sumitra Thongprasert received the 2016 IASLC Merit Award, which is given to lung cancer specialists who have made extraordinary contributions to the IASLC’s development. Dr. Thongprasert is Professor Emeritus, Faculty of Medicine, Chiang Mai University; Senior Consultant in Oncology, Bangkok Hospital Chiang Mai; and Director, Bangkok Hospital Chiang Mai Center of Excellence in…
-
Gerard A. Silvestri, MD, MS, FCCP
Posted: February 2017 Gerard A. Silvestri is the 79th President of the American College of Chest Physicians, effective November 2017. Dr. Silvestri is Hillenbrand Professor of Thoracic Oncology and Vice-Chair of Medicine for Faculty Development at the Medical University of South Carolina in Charleston, US.
-
John C. Ruckdeschel, MD
Posted: February 2017 John C. Ruckdeschel has been appointed Director, University of Mississippi Medical Center Cancer Institute, Jackson, MS. Previous to this appointment, Dr. Ruckdeschel was Medical Director, Oncology Program and Services, Intermountain Healthcare, Greater Salt Lake City Area, US.
-
Ugo Pastorino, MD
Posted: February 2017 Ugo Pastorino received the Joseph W. Cullen/Early Detection Award, which is given to to a lung cancer specialist in recognition of his or her scientific achievements in research on the prevention of thoracic malignancies. Dr. Pastorino is Director, Thoracic Surgery Division, Istituto Nazionale Tumori, Milan, Italy; and Faculty Member, School of Specialization in…
-
Keunchil Park, MD, PhD
Posted: February 2017 Keunchil Park received the 2016 IASLC Merit Award, which is given to lung cancer specialists who have made extraordinary contributions to the IASLC’s development. Dr. Park is Professor, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine in Seoul, South Korea.
-
Dr. Benjamin Levy, MD
Posted: February 2017 Dr. Benjamin Levy has been appointed Clinical Director, Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and Medical Director of the Thoracic Oncology Program in Washington, D.C. Prior to this appointment, Dr. Levy was Director of Thoracic Medical Oncology, Mount Sinai Health Systems and Associate Director, Cancer Clinical Trials Office, Mount…
-
Keith Kerr, BSc, MB ChB, FRCPath, FRCPE
Posted: February 2017 Keith Kerr received the 2016 IASLC Mary J. Matthews Pathology/ Translational Research Award, which is given to a scientist for lifetime scientific achievements in pathology/translational research of thoracic malignancies. Dr. Kerr is Honorary Professor of Pulmonary Pathology at Aberdeen University Medical School in Scotland, UK.
-
Roy S. Herbst, MD, PhD
Posted: February 2017 Roy S. Herbst received the 2016 IASLC Paul A. Bunn, Jr. Scientific Award, which is given to an oncologist who has made outstanding scientific contributions to thoracic cancer research. Dr. Herbst is Ensign Professor of Medicine; Professor of Pharmacology; Chief of Medical Oncology; Director of the Thoracic Oncology Research Program; and Associate Director…